6 Recruiting Classical Hodgkin Lymphoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Classical Hodgkin Lymphoma
Top Recruiting Classical Hodgkin Lymphoma Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above
📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma
📍 New York Medical College — Valhalla, New York
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
📍 Princess Margaret Cancer Centre — Toronto, Ontario
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Itacitinib + Everolimus in Hodgkin Lymphoma
📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
📍 Winship Cancer Center of Emory University — Atlanta, Georgia
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔